| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4321380 | Neuron | 2012 | 4 Pages |
Abstract
Despite the need for more effective treatments for psychiatric disorders, development of new medications has stalled. Here we discuss the promise of personalized medicine in developing more efficacious and individualized pharmacotherapies that take into account genetic variation and target groups of patients who share biology, not just symptoms.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Francis J. McMahon, Thomas R. Insel,